Minde Zeng
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Pharmacokinetics, pharmacodynamics and safety of 15 mg-tolvaptan administered orally for 7 consecutive days to Chinese patients with child-Pugh B cirrhosis.
Journal: Frontiers in pharmacology
Published: October 27, 2023
Exploring the efficacy and safety of polyene phosphatidylcholine for treatment of drug-induced liver injury using the Roussel Uclaf causality assessment method: a propensity score matching comparison.
Journal: The Journal of international medical research
Published: August 26, 2021
Tolvaptan therapy of Chinese cirrhotic patients with ascites after insufficient diuretic routine medication responses: a phase III clinical trial.
Journal: BMC gastroenterology
Published: January 14, 2020
Efficacy and safety of magnesium isoglycyrrhizinate injection in patients with acute drug-induced liver injury: A phase II trial.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: October 30, 2018
A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis.
Journal: Medicine
Published: November 29, 2016
The aggravation of mitochondrial dysfunction in nonalcoholic fatty liver disease accompanied with type 2 diabetes mellitus.
Journal: Scandinavian journal of gastroenterology
Published: April 17, 2015
S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis.
Journal: PloS one
Published: December 04, 2014
Transient elastography compared to serum markers to predict liver fibrosis in a cohort of Chinese patients with chronic hepatitis B.
Journal: Journal of gastroenterology and hepatology
Published: October 15, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026